EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CAPG serves as a prognostic biomarker and promotes proliferation and migration in pancreatic ductal adenocarcinoma

Zhongyu Qin iD, Kaixia Li, Xuanjie Li, Haorui Wang, Yiqiang Zhang

PLOS One · 31.03.2026 · 21 (3) · e0346011

DOI: 10.1371/journal.pone.0346011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 31.03.2026. Verfasst von Zhongyu Qin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Changzhi Medical College, Changzhi, Shanxi, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Cell Movement, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Program for Higher Education Institutions of Shanxi Province, the Fundamental Research Program of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The actin-binding protein CAPG (Capping Actin Protein, Gelsolin Like) is implicated in oncogenesis, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unclear. This study combined bioinformatic analysis of TCGA/GEO datasets, immunohistochemistry on clinical samples, and functional in vitro assays to define CAPG’s significance in PDAC. We found CAPG significantly overexpressed in PDAC tissues (n = 179 tumor vs. 171 normal, p < 0.05), with levels correlating with advanced tumor stage (T3 vs. T1) and predicting poorer overall (p = 0.0085) and disease-free (p = 0.015) survival. In vitro, siRNA-mediated CAPG knockdown in PANC-1 and AsPC-1 cells markedly inhibited proliferation (CCK-8 assay) and migration (wound healing assay), and significantly sensitized cells to gemcitabine-induced apoptosis. Mechanistically, CAPG knockdown was associated with reduced ERK1/2 phosphorylation and Cyclin D1 expression, and ERK1/2 inhibition phenocopied the anti-proliferative and chemosensitizing effects. Our results establish CAPG as a negative prognostic biomarker in PDAC, demonstrate its critical role in driving proliferation and migration—potentially via modulating ERK pathway activity—and highlight its promise as a therapeutic target whose inhibition can enhance chemotherapy efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalCell MovementPancreatic NeoplasmsBiomarkers, TumorMicrofilament ProteinsHumansCell ProliferationPrognosisCell Line, TumorFemaleDeoxycytidineApoptosisGene Expression Regulation, NeoplasticMaleGemcitabineMiddle AgedNuclear Proteins

Substanzen

Biomarkers, TumorCAPG protein, humanMicrofilament ProteinsDeoxycytidineGemcitabineNuclear Proteins

Autor:innen und Institutionen

  • Department of Basic Medicine, Changzhi Medical College, Changzhi, Shanxi, China.

ORCID-Profile: Zhongyu Qin

Förderung

  • Science and Technology Innovation Program for Higher Education Institutions of Shanxi Province
  • the Fundamental Research Program of Shanxi Province

Zitieren

APA

Qin, Z., Li, K., Li, X., Wang, H., & Zhang, Y. (2026). CAPG serves as a prognostic biomarker and promotes proliferation and migration in pancreatic ductal adenocarcinoma. PLOS One, 21(3), e0346011. https://doi.org/10.1371/journal.pone.0346011

Vancouver

Qin Z, Li K, Li X, Wang H, Zhang Y. CAPG serves as a prognostic biomarker and promotes proliferation and migration in pancreatic ductal adenocarcinoma. PLOS One. 2026;21(3):e0346011. doi:10.1371/journal.pone.0346011

BibTeX
@article{Qin2026,
  author = {Qin, Zhongyu and Li, Kaixia and Li, Xuanjie and Wang, Haorui and Zhang, Yiqiang},
  title = {CAPG serves as a prognostic biomarker and promotes proliferation and migration in pancreatic ductal adenocarcinoma},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0346011},
  doi = {10.1371/journal.pone.0346011}
}
Kostenlos starten →